Covid Vaccine bloodbath continues - with a few exceptions

Miserable end to a miserable week as red ink keeps flowing. The average loss for these stocks was 2.2% today. For the third day out of four, 20 stocks fell with 8 gaining value. Only Arcturus Therapeutics has managed to gain on all three of these days and on each day this week.

BioNTech had a strong day - up over 10% based on positive pre-clinical data from its work with Pfizer on a vaccine. Biondvax was the next top performing stock - up over 9%. Arcturus was up by 6.5% and little OncoSec managed to gain almost 5%.

Besides these notable winners, it was a very down day for these stocks. iBio continued its descent with another 13% drop. GeoVax lost almost 11%. There were several other companies with high single digit losses: Sorrento, Altimmune, NantKwest, VBI, Vaxart, Generex, Tonix and Inovio.

After an amazing return of 4.5% on average on Monday, thanks to the CureVac IPO, the week went straight south losing 6.5% in total.